MENA Microbiome
From Biomarkers Discovery
to Microbiota-based Therapeutics
Date: 28-29 September 2024
Venue: The Plaza Doha
Agenda
7:00 – 8:00 am | Registration/Check-in | |
Time | Speaker | Talk Time |
8:00 – 8:10 am | Dr. Souhaila Al Khodor, MENA Microbiome Chair
Dr. Annalisa Terranegra, MENA Microbiome Chair Dr. Khalid Fakhro, Chief Research Officer, Sidra Medicine |
Welcome Notes |
8:10 – 8:15 am | TBC | |
8:15 – 8:30 am | Dr. Rayana Bou Haka Head of Office World Health Organization- Qatar Dr. Abdullatif Al Khal Deputy Chief Medical Officer Hamad Medical Corporation, Qatar |
Opening remarks |
8:30 – 8:45 am | TBC | TBC |
8:45 – 10:30 am | Session I: Keeping the balance between health and disease – Role of the Microbiome
Learning objectives:
Session Chairs:
|
|
8:45 – 9:30 am | Prof. Alessio Fasano Chief of the Division of Pediatric Gastroenterology and Nutrition Professor of Pediatrics, Harvard Medical School, MA, USA |
Keynote Lecture:
Microbiome, Gut Permeability, And Immune Response: The Triangulation Dictating the Balance Between Health and Disease |
9:30 – 9:55 am | Dr. Souhaila Al Khodor Director of the Reproductive and Perinatal Health Division Sidra Medicine, Qatar |
Multi-Omics of microbial and host factors for a better understanding of Pediatric Inflammatory Bowel Disease |
9:55 – 10:20 am | Dr. Farah Al-Marzooq Assistant Professor, Department of Medical Microbiology and Immunology United Arab Emirates University, UAE |
Salivary microbiome signature in patients with Crohn’s disease |
10:20 – 10:30 am | Short Oral Talk | O1 |
10:30 – 11:00 am | Coffee break
Poster viewing and exhibition visit |
|
11:00 am – 2:00 pm | Session II: Diet, Lifestyle & the Microbiome
Learning objectives:
Session Chairs:
|
|
11:00 – 11:25 am | Dr. Heli Viljakainen Group leader, Department of Food and Nutrition University of Helsinki, Finland |
Associations of central Childhood obesity and habitual food consumption with saliva microbiota and its enzymatic profiles. |
11:25 – 11:50 am | Dr. Vibeke H. Telle-Hansen Associate Professor Oslo Metropolitan University, Norway |
Testing the beneficial effect of PUFA on the microbiome and cholesterol levels in healthy individuals: A randomized crossover trial. |
11:50 am – 12:00 pm | Short Oral Talk | O2 |
12:00 – 1:00 pm | Lunch
Poster viewing and judging |
|
1:00 – 1:25 pm | Dr. Annalisa Terranegra Principal Investigator Precision Nutrition Sidra Medicine, Qatar |
Precision nutrition approach to pediatric type 1 diabetes |
1:25 – 1:50 pm | Dr. Mohammad T Albataineh Assistant Professor, Molecular Biology and Genetics, College of Medicine and Health Sciences Khalifa University, UAE |
Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers |
1:50 – 2:00 pm | Short Oral Talk | O3 |
2:00 – 4:35 pm | Session III: Bugs as drugs: Microbiome-based Therapeutics
Learning objectives:
Session Chairs:
|
|
2:00 – 2:25 pm | Dr. Amine Zorgani Founder – The Microbiome Mavericks Consultant Biocodex Microbiota Institute, Belgium |
Microbiome therapeutics: Past, Present, and Future |
2:25 – 2:50 pm | Dr. Mamoun Elawad Chief of the Division of Pediatric Gastroenterology and Nutrition Sidra Medicine, Qatar |
Faecal Material Transplantation in Inflammatory Bowel disease |
2:50 – 3:15 pm | Prof. Sunny Wong Associate Professor and Assistant Dean at the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore |
Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial |
3:15 – 3:45 pm | Coffee Break
Poster viewing and judging |
|
3:45 – 4:10 pm | Dr. Elisabetta Volpe Head of Molecular Neuroimmunology Laboratory IRCCS Fondazione Santa Lucia, Italy |
Microbiome in Pediatric Autism: can microbial intervention improve the social behaviour? |
4:10 – 4:35 pm | Dr. Nezar Al-Hebshi Associate Professor- Co Director, Oral Microbiome Research Laboratory Temple University, PA, USA |
Role of the Oral Microbiome in Health and Disease: can we quantify dysbiosis? |
4:35 – 5:00 pm | Prof. Marvin Edeas Department Endocrinology, Metabolism and Diabetes Université de Paris, INSERM, Institute Cochin, France |
Targeting Microbiota Dysbiosis: Barriers and Perspectives |
5:00 – 5:45 pm | Panel Discussion
Panel members: TBC
|
|
5:45 – 6:00 pm | Closing remarks for Day 1 | MENA Microbiome conference Chairs |
7:00 – 8:00 am | Registration/Check-in | |
8:00 am – 12:00 pm | Session IV: The Gut Microbiome: Connecting Health Across Organs
Learning objectives:
Session Chairs:
|
|
8:00 – 8:45 am | Prof. Peer Bork Director of EMBL Heidelberg, Germany |
Keynote Lecture II:
Gut microbiome analysis for human health and wellbeing |
8:45 – 9:10 am | Prof. Emmanuelle Maguin Director, French National Institute for Agriculture, Food, and Environment (INRAE), France |
The food and microbiome interplay for health |
9:10 – 9:35 am | Dr. Amelia McGuinness Associate Research Fellow, Deakin University |
The Microbiome-Gut-Brain Axis: The Bacteriome and Beyond |
9:35 – 10:00 am | Dr. Greg Tasian Attending Pediatric Urologist, Division of Urology Children’s Hospital of Philadelphia, PA, USA |
The Gut-Kidney Axis of Kidney Stone Disease: A Pathway to Novel Diagnostics and Therapeutics |
10:00 – 10:05 am | Patient Success story | Manipulation of the microbiome through diet can improve clinical outcomes: A story from an IBD-Autistic patient at Sidra Medicine |
10:05 – 10:35 am | Coffee break
Poster viewing and judging |
|
10:35 – 11:00 am | Prof. Nahla Mansour Professor of Microbial Molecular Biology National Research Center, Egypt |
Gut Microbiome Analysis in Type 2 Diabetes Egyptians: Towards Personalized Medicine |
11:00 – 11:25 am | TBC | TBC |
11:25 – 11:50 am | Prof. Mohammad Issa El Mouzan Professor of Pediatrics, College of Medicine, King Saud University, Saudi Arabia |
Gut Virome and Mycobiome in the Saudi pediatric population |
11:50 – 12:00 pm | Short Oral Talk | O4 |
12:00 – 12:10 pm | Short Oral Talk | O5 |
12:10 – 12:20 pm | Short Oral Talk | O6 |
12:20 – 1:30 pm | Lunch
Poster viewing and judging |
|
1:00 – 3:05 pm | Session V: Microbiome in Women and neonatal Health
Learning objectives: |
|
1:30 -1:55 pm | Prof. Phillip Bennett Director of Institute of Reproductive and Developmental Biology, Professor of Obstetrics and Gynaecology Imperial College London, UK |
Microbiome aspects of fertility, miscarriage, and preterm birth |
1:55 – 2:20 pm | Dr. Maha Al Asmakh Department Head of Biomedical Sciences Associate Professor, Qatar University, Qatar |
Salivary Microbiome in pregnancy |
2:20 – 2:45 pm | Prof. Erika Isolauri Professor of Pediatrics Head of the Department of Clinical Medicine, Faculty of Medicine, University of Turku, Finland |
Resilience to risk exposures in the preterm child through the microbiome |
2:45 – 3:10 pm | Dr. Ahmed Mustafa Sequencing Core Director of the Microbiome Center Children’s Hospital of Philadelphia, PA, USA |
Empowering Global Disease Surveillance: Leveraging Microbial Genomics, Big Data Mining, and Environmental Microbiome Analysis to Understand Infectious Diseases |
3:10 – 3:35 pm | Dr. Ibrahim Hassan Senior attending Physician, Microbiology and Virology, Sidra Medicine, Qatar |
Antimicrobial stewardship and microbiome in the pediatric population: Where are we? |
3:35 – 4:00 pm | Coffee Break
Poster viewing and judging |
|
4:00 – 5:30 pm | Microbiome Documentary Screening:
The Invisible Extinction |
Martin Blaser Professor, Medicine and Microbiology, Robert Wood Johnson Medical School, NJ, USAMaria Gloria Dominguez Bello Professor, Department of Biochemistry and Microbiology, Rutgers School of Environmental and Biological Sciences, NJ, USA |
5:30 – 5:45 pm | Closing remarks for Day 2 & Posters Award Announcement |
MENA Microbiome conference Chairs |